Dr. Andres Schanzer, MD, is an Assistant Professor in the Division of Vascular and
Endovascular Surgery at the University of Massachusetts Memorial Medical Center. He
serves as the program director of the Integrated Vascular Surgery Residency Program. He
also holds a secondary appointment in the Department of Quantitative Health Sciences at
the University of Massachusetts Medical School. Dr. Schanzer has been actively involved
in outcomes research with a focus on developing risk prediction tools to better inform
decision-making prior to vascular surgical procedures. The PIII Critical Limb Ischemia
Risk score was originally derived using the PREVENT III randomized trial cohort and has
now been validated in both the United States and Europe. This risk prediction tool has
been widely cited and is now commonly used to predict the likelihood of amputation-free
survival after lower extremity bypass for critical limb ischemia. Dr. Schanzer has also
been actively involved in generating the risk adjustment models used by the quality
improvement group known as the Vascular Surgery Group of New England. This program is now
being emulated at the national level by the Society of Vascular Surgery and Dr. Schanzer
continues to play an active role through his participation on the Research Advisory
Committee.
Articles
Contributions to Books
